MedTrace Logo

Evaluating Home Testing Devices for the Management of Glaucoma

NCT05325996 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2025-11-14

No results posted yet for this study

Summary

With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.

Conditions

  • Glaucoma, Open-Angle

Interventions

DIAGNOSTIC_TEST

Standard Automatic Perimetry Humphrey Field Analyzer

Standard Automatic Perimetry (SAP) using the Swedish Interactive Threshold Algorithm (SITA) Standard Strategy measures the visual field in an ophthalmic setting.

DIAGNOSTIC_TEST

visuALL H

visuALL H a new portable perimeter measuring the visual field and acuity in a non ophthalmic setting.

DIAGNOSTIC_TEST

iCare Home Tonometer

iCare HOME tonometer is a device developed for patients/subjects to measure their eye pressure at home.

DIAGNOSTIC_TEST

Spectralis Optical coherence tomography (OCT)

Optical coherence tomography (OCT) is a computerized picture measuring the thickness of the inner layer of the retina that makes the optic nerve.

Sponsors & Collaborators

  • Wills Eye

    lead OTHER

Principal Investigators

  • M. Reza Razeghinejad, MD · Wills Eye Hospital

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-15
Primary Completion
2025-02-17
Completion
2025-02-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05325996 on ClinicalTrials.gov